Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Chargement...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Rhodiola rosea
Calculateur gratuit de posologie — doses adultes et enfants selon le poids.
Rhodiola rosea pousse dans les régions froides et montagneuses d'Europe et d'Asie et est utilisée en médecine traditionnelle en Russie et en Scandinavie depuis des siècles. Elle est classée comme adaptogène, aidant l'organisme à résister au stress physique et mental. Elle a gagné une popularité significative en tant qu'améliorateur naturel de performance et stabilisateur de l'humeur.
Rhodiola (Rhodiola rosea) is an adaptogen with over 2000 years of traditional use in Arctic regions. Standardized extracts (3% rosavins, 1% salidroside) demonstrate benefits for stress, fatigue, and mood. Level B evidence supports its use for physical and mental fatigue in stressful situations, with rapid onset (3-7 days). Unlike many adaptogens, it has stimulating properties and should be taken in the morning. The dual rosavin/salidroside ratio is critical for efficacy.
Rhodiola contains rosavins (rosavin, rosin, rosarin—unique to R. rosea) and salidroside (rhodioloside). Rosavins predominate in the root; salidroside is more concentrated in the rhizome. The mechanism involves modulation of the hypothalamic-pituitary-adrenal (HPA) axis, reducing cortisol response to stress. It increases beta-endorphins and monoamines (serotonin, dopamine, norepinephrine). Rhodiola also enhances mitochondrial function and ATP production. MAO-A inhibition may contribute to mood effects. The adaptogenic effect is bidirectional—normalizing both high and low cortisol states.
Rhodiola rosea pousse dans les régions froides et montagneuses d'Europe et d'Asie et est utilisée en médecine traditionnelle en Russie et en Scandinavie depuis des siècles. Elle est classée comme adaptogène, aidant l'organisme à résister au stress physique et mental. Elle a gagné une popularité significative en tant qu'améliorateur naturel de performance et stabilisateur de l'humeur.
Rhodiola (Rhodiola rosea) is an adaptogen with over 2000 years of traditional use in Arctic regions. Standardized extracts (3% rosavins, 1% salidroside) demonstrate benefits for stress, fatigue, and mood. Level B evidence supports its use for physical and mental fatigue in stressful situations, with rapid onset (3-7 days). Unlike many adaptogens, it has stimulating properties and should be taken in the morning. The dual rosavin/salidroside ratio is critical for efficacy.
Rhodiola contains rosavins (rosavin, rosin, rosarin—unique to R. rosea) and salidroside (rhodioloside). Rosavins predominate in the root; salidroside is more concentrated in the rhizome. The mechanism involves modulation of the hypothalamic-pituitary-adrenal (HPA) axis, reducing cortisol response to stress. It increases beta-endorphins and monoamines (serotonin, dopamine, norepinephrine). Rhodiola also enhances mitochondrial function and ATP production. MAO-A inhibition may contribute to mood effects. The adaptogenic effect is bidirectional—normalizing both high and low cortisol states.
Rhodiola rosea works primarily through its active compounds, rosavins and salidroside, which influence key neurotransmitters including serotonin, dopamine, and norepinephrine. These compounds help regulate the body's stress response by modulating cortisol release and supporting the hypothalamic-pituitary-adrenal (HPA) axis. As an adaptogen, Rhodiola enhances cellular energy metabolism by increasing ATP production and improving mitochondrial function. Research suggests it also provides neuroprotective effects through antioxidant activity. (Evidence Level: B)
Rhodiola rosea may interact with several medication classes. Due to its effects on serotonin and dopamine, it should not be combined with antidepressants, particularly MAO inhibitors and SSRIs, as this may increase the risk of serotonin syndrome. Rhodiola may potentiate the effects of stimulant medications, increasing the risk of side effects like elevated blood pressure and heart rate. Those taking blood thinners or diabetes medications should consult a healthcare provider, as Rhodiola may affect blood clotting and glucose levels. (Evidence Level: B)
The standard adult dosage for Rhodiola rosea is 200-600mg daily of a standardized extract containing 3% rosavins and 1% salidroside. For fatigue and stress, clinical studies typically use doses at the lower end (200-400mg), while endurance and performance enhancement may benefit from doses at the higher end (400-600mg). Rhodiola is best taken on an empty stomach before breakfast or lunch, as taking it later in the day may cause insomnia. (Evidence Level: B)
Rhodiola rosea is not considered safe during pregnancy or breastfeeding and should be avoided. There is insufficient safety data for use in these populations, and Rhodiola's effects on hormones and neurotransmitters could potentially affect fetal development or infant health. Additionally, Rhodiola's stimulant-like properties may pose risks during pregnancy. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using any adaptogenic herbs. (Evidence Level: D - insufficient data)
Rhodiola rosea has shown promise as a natural support for mild to moderate depression. Clinical studies suggest it may help improve mood, reduce fatigue, and enhance mental performance in individuals with depression-related symptoms. The herb's adaptogenic properties help the body manage stress, which is often linked to anxiety and depression. However, Rhodiola should not replace prescribed antidepressant medications without medical supervision, and individuals with bipolar disorder should avoid it due to potential manic episodes. (Evidence Level: B)